Cite
HARVARD Citation
Rubin, J. et al. (2022). Limitations of standard cost-effectiveness methods for health technology assessment of treatments for rare, chronic diseases: a case study of treatment for cystic fibrosis. Journal of medical economics. pp. 783-791. [Online].